Effect of Curcumin and Its Derivates on Gastric Cancer: Molecular Mechanisms

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA. 2016;66:7–30.
   Google Scholar
• Shah MA, Kelsen DP. Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw. 2010;8(4):437–47. doi:10.6004/jnccn.2010.0033
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yasui W, Yokozaki H, Naka K, Ishikawa T, Tahara E. Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer. 1999;81(4):535–8. doi:10.1002/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Tanaka S, Yoshihara M, Shimamoto F, Chayama K. K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer. 2002;97(5):562–6. doi:10.1002/ijc.1644
   PubMed Web of Science ®Google Scholar
• Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol . 2006;60(3):273–7. doi:10.1136/jcp.2006.038778
   PubMed Web of Science ®Google Scholar
• Cheng X-X, Wang Z-C, Chen X-Y, Sun Y, Kong Q-Y, Liu J, Li H. Correlation of Wnt-2 expression and β-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cancer Lett. 2005;223(2):339–47. doi:10.1016/j.canlet.2004.11.013
   PubMed Web of Science ®Google Scholar
• Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, Horii A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet. 1992;1(8):559–63. doi:10.1093/hmg/1.8.559
   PubMed Web of Science ®Google Scholar
• Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, et al. β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 2002;62:3503–6.:
   PubMed Web of Science ®Google Scholar
• Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, et al. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res. 1999;59(17):4257–60.:
   PubMed Web of Science ®Google Scholar
• Zhang X, Yashiro M, Ren J, Hirakawa K. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. Oncol. Rep. 2006;16(3):563–8.
   PubMed Web of Science ®Google Scholar
• Hatcher H, Planalp R, Cho J, Torti F, Torti S. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631–52. doi:10.1007/s00018-008-7452-4
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081–7. doi:10.1016/j.lfs.2005.12.007
   PubMed Web of Science ®Google Scholar
• Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999;59(3):597–601.
   PubMed Web of Science ®Google Scholar
• Parsamanesh N, Moossavi M, Bahrami A, Butler AE, Sahebkar A. Therapeutic potential of curcumin in diabetic complications. Pharmacol Res. 2018;136:181–93. doi:10.1016/j.phrs.2018.09.012
   PubMed Web of Science ®Google Scholar
• Hatamipour M, Johnston TP, Sahebkar A. One molecule, many targets and numerous effects: the pleiotropy of curcumin lies in its chemical structure. Curr Pharm Des. 2018;24(19):2129–36. doi:10.2174/1381612824666180522111036
   PubMed Web of Science ®Google Scholar
• Negi P, Jayaprakasha G, Jagan Mohan Rao L, Sakariah K. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999;47(10):4297–300. doi:10.1021/jf990308d
   PubMed Web of Science ®Google Scholar
• Srimal R, Dhawan B. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent . J Pharm Pharmacol. 1973;25(6):447–52. doi:10.1111/j.2042-7158.1973.tb09131.x
   PubMed Web of Science ®Google Scholar
• Toda T, Uno I, Ishikawa T, Powers S, Kataoka T, Broek D, Cameron S, Broach J, Matsumoto K, Wigler M. In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell. 1985;40(1):27–36. doi:10.1016/0092-8674(85)90305-8
   PubMed Web of Science ®Google Scholar
• Kuttan R, Bhanumathy P, Nirmala K, George M. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985;29(2):197–202. doi:10.1016/0304-3835(85)90159-4
   PubMed Web of Science ®Google Scholar
• Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, Ariakia F, Fiuji H, Sahebkar A, Avan A, et al. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer . J Cell Physiol. 2018;233(10):6785–98.: doi:10.1002/jcp.26538
   PubMed Web of Science ®Google Scholar
• Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? Aaps J. 2009;11(3):495–510. doi:10.1208/s12248-009-9128-x
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Alkahtani SA, Akhter S, Ahmad FJ, Ahmad J, Akhtar MS, Mohsin N, Abdel-Wahab BA. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art. J Drug Target. 2016;24(4):273–93. doi:10.3109/1061186X.2015.1055570
   PubMed Web of Science ®Google Scholar
• Huang M-T, Wang Z, Georgiadis C, Laskin J, Conney A. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene . Carcinogenesis. 1992;13(11):2183–6. doi:10.1093/carcin/13.11.2183
   PubMed Web of Science ®Google Scholar
• Conney AH, Lysz T, Ferraro T, Abidi TF, Manchand PS, Laskin JD, Huang MT. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul. 1991;31:385–96. doi:10.1016/0065-2571(91)90025-h
   PubMedGoogle Scholar
• Huang M-T, Smart RC, Wong C-Q, Conney AH. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1988;48(21):5941–6.
   PubMed Web of Science ®Google Scholar
• Ramachandran C, Rodriguez S, Ramachandran R, Nair PR, Fonseca H, et al. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 2005;25:3293–302.:
   PubMed Web of Science ®Google Scholar
• Xue X, Yu J-L, Sun D-Q, Kong F, Qu X-j, Zou W, Wu J, Wang R-M. Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways. Asian Pac J Cancer Prev. 2014;15(9):3987–92. doi:10.7314/apjcp.2014.15.9.3987
   PubMedGoogle Scholar
• Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1A):363–98.
   PubMed Web of Science ®Google Scholar
• Tu SP, Jin H, Shi JD, Zhu LM, Suo Y, Lu G, Liu A, Wang TC, Yang CS. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res (Phila)). 2012;5(2):205–15. doi:10.1158/1940-6207.CAPR-11-0247
   PubMed Web of Science ®Google Scholar
• Zheng R, Deng Q, Liu Y, Zhao P. Curcumin inhibits gastric carcinoma cell growth and induces apoptosis by suppressing the Wnt/β-catenin signaling pathway. Med Sci Monit. 2017;23:163–71. doi:10.12659/msm.902711
   PubMed Web of Science ®Google Scholar
• Li Y, Tan B-b, Zhao Q, Fan L-q, Liu Y, Wang D. Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells. Mol Biol Rep. 2014;41(6):3603–10. doi:10.1007/s11033-014-3224-4
   PubMed Web of Science ®Google Scholar
• Xu H, Yu W, Yu W, Zhang M, Ma Y, et al. Curcumin inhibits gastric cancer growth via down-regulation of zinc finger protein, ZNF139. Trop J Pharm Res. 2019;18.:
   Web of Science ®Google Scholar
• Hatakeyama K, Yamakawa Y, Fukuda Y, Ohshima K, Wakabayashi-Nakao K, Sakura N, Tanizawa Y, Kinugasa Y, Yamaguchi K, Terashima M, et al. A novel splice variant of XIAP-associated factor 1 (XAF1) is expressed in peripheral blood containing gastric cancer-derived circulating tumor cells. Gastric Cancer. 2015;18(4):751–61.: doi:10.1007/s10120-014-0426-3
   PubMed Web of Science ®Google Scholar
• Xue LJ, Mao XB, Ren LL, Chu XY. Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma. Cancer Med. 2017;6(6):1424–36. doi:10.1002/cam4.1085
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer. 2004;111(5):679–92. doi:10.1002/ijc.20333
   PubMed Web of Science ®Google Scholar
• Liu C-A, Wang M-J, Chi C-W, Wu C-W, Chen J-Y. Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis . Oncogene. 2004;23(54):8731–42. doi:10.1038/sj.onc.1208106
   PubMed Web of Science ®Google Scholar
• Amerizadeh F, Khazaei M, Maftouh M, Mardani R, Bahrami A. miRNA targeting angiogenesis as a potential therapeutic approach in the treatment of colorectal cancers. Curr Pharm Des. 2018;24(39):4668–74. doi:10.2174/1381612825666190110161843
   PubMed Web of Science ®Google Scholar
• Huang F, Yao Y, Wu J, Liu Q, Zhang J, Pu X, Zhang Q, Xia L. Curcumin inhibits gastric cancer-derived mesenchymal stem cells mediated angiogenesis by regulating NF-κB/VEGF signaling. Am J Transl Res. 2017;9(12):5538–47.
   PubMed Web of Science ®Google Scholar
• Moragoda L, Jaszewski R, Majumdar AP. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Gastroenterology. 2001;120(5):A666–A666. doi:10.1016/S0016-5085(08)83313-6
   Web of Science ®Google Scholar
• Liang T, Zhang X, Xue W, Zhao S, Zhang X, Pei J. Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway. Int J Mol Sci. 2014;15(9):15754–65. doi:10.3390/ijms150915754
   PubMed Web of Science ®Google Scholar
• Aggarwal B, Bhatt ID, Ichikawa H, Ahn KS, Sethi G, et al. Curcumin-biological and medicinal properties. Turmeric. 2007;297–368.
   Google Scholar
• Moos PJ, Edes K, Mullally JE, Fitzpatrick FA. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis. 2004;25(9):1611–7. doi:10.1093/carcin/bgh163
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci USA. 2005;102(15):5535–40. doi:10.1073/pnas.0501828102
   PubMed Web of Science ®Google Scholar
• Fu H, Wang C, Yang D, Wei Z, Xu J, Hu Z, Zhang Y, Wang W, Yan R, Cai Q. Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling. J Cell Physiol. 2018;233(6):4634–42. doi:10.1002/jcp.26190
   PubMed Web of Science ®Google Scholar
• Bahrami A, Hasanzadeh M, Hassanian SM, ShahidSales S, Ghayour-Mobarhan M, Ferns GA, Avan A. The potential value of the PI3K/Akt/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy. J Cell Biochem. 2017;118(12):4163–9. doi:10.1002/jcb.26118
   PubMed Web of Science ®Google Scholar
• Gnanasekar M, Thirugnanam S, Ramaswamy K. Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis. Int J Oncol. 2009;34(2):425–31.
   PubMed Web of Science ®Google Scholar
• Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T, et al. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J Cell Sci. 1999;112:1257–71.:
   PubMed Web of Science ®Google Scholar
• Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G, Atkinson AR, Busso D, Poussin P, Marine J-C, et al. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 2008;15(8):1211–20.: doi:10.1038/cdd.2008.18
   PubMed Web of Science ®Google Scholar
• Cai XZ, Huang WY, Qiao Y, Du SY, Chen Y, Chen D, Yu S, Che RC, Liu N, Jiang Y. Inhibitory effects of curcumin on gastric cancer cells: A proteomic study of molecular targets. Phytomedicine. 2013;20(6):495–505. doi:10.1016/j.phymed.2012.12.007
   PubMed Web of Science ®Google Scholar
• Yu G, Wang JJun, Chen Y, Wang X, Pan J, Li Q, Xie K. Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis. 2008;25(7):695–702. doi:10.1007/s10585-008-9178-y
   PubMed Web of Science ®Google Scholar
• Li W, Zhou Y, Yang J, Li H, Zhang H, Zheng P. Curcumin induces apoptotic cell death and protective autophagy in human gastric cancer cells. Oncol Rep. 2017;37(6):3459–66. doi:10.3892/or.2017.5637
   PubMed Web of Science ®Google Scholar
• Bahrami A, Bianconi V, Pirro M, Orafai HM, Sahebkar A. The role of TFEB in tumor cell autophagy: Diagnostic and therapeutic opportunities. Life Sci. 2020;244:117341. doi:10.1016/j.lfs.2020.117341
   PubMed Web of Science ®Google Scholar
• Bahrami A, Majeed M, Sahebkar A. Curcumin: A potent agent to reverse epithelial-to-mesenchymal transition. Cell Oncol. 2019;42(4):405–17. doi:10.1007/s13402-019-00442-2
   Web of Science ®Google Scholar
• Cheng X, Chen N, Wang W, Niu Q, Li Q, et al. Inhibitory effects of curcumin on epithelial-mesenchymal transition in human gastric cancer cells and the possible mechanism. Int J Clin Exp Med. 2018;11:6973–9.
   Web of Science ®Google Scholar
• Yao J, Zheng K, Li C, Liu H, Shan X. Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1–Hes-1 signaling pathway. Med Oncol. 2015;32(6):174. doi:10.1007/s12032-015-0610-2
   Web of Science ®Google Scholar
• Bahrami A, Khazaei M, Hassanian SM, ShahidSales S, Joudi-Mashhad M, Maftouh M, Jazayeri MH, Parizade MR, Ferns GA, Avan A. Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress. J Cell Physiol. 2018;233(4):2928–36. doi:10.1002/jcp.26041
   PubMed Web of Science ®Google Scholar
• Liu W, Huang M, Zou Q, Lin W. Curcumin suppresses gastric cancer biological activity by regulation of miRNA-21: an in vitro study. Int J Clin Exp Path. 2018;11:5820.
   PubMed Web of Science ®Google Scholar
• Silva G, Teixeira Lima F, Seba V, Mendes Lourenço A, Lucas T, de Andrade B, Torrezan G, Polaquini C, Garcia M, Couto L, et al. Curcumin analog CH-5 suppresses the proliferation, migration, and invasion of the human gastric cancer cell line HGC-27. Molecules. 2018;23(2):279.: doi:10.3390/molecules23020279
   PubMed Web of Science ®Google Scholar
• Cai X-Z, Wang J, Li X-D, Wang G-L, Liu F-N, Cheng M-S, Li F. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther. 2009;8(14):1360–8. doi:10.4161/cbt.8.14.8720
   PubMed Web of Science ®Google Scholar
• Brambilla D, Fais S. The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype. Int J Cancer. 2009;125(10):2239–45. doi:10.1002/ijc.24734
   PubMed Web of Science ®Google Scholar
• Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 2004;10(2):182–6. doi:10.1038/nm982
   PubMed Web of Science ®Google Scholar
• Bahrami A, Amerizadeh F, ShahidSales S, Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR, Maftouh M, Hassanian SM, Avan A. Therapeutic potential of targeting Wnt/β-Catenin pathway in treatment of colorectal cancer: rational and progress. J Cell Biochem. 2017;118(8):1979–83. doi:10.1002/jcb.25903
   PubMed Web of Science ®Google Scholar
• Park CH, Hahm ER, Park S, Kim H-K, Yang CH. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling . FEBS Lett. 2005;579(13):2965–71. doi:10.1016/j.febslet.2005.04.013
   PubMed Web of Science ®Google Scholar
• Jaiswal AS, Marlow BP, Gupta N, Narayan S. β-Catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene. 2002;21(55):8414–27. doi:10.1038/sj.onc.1205947
   PubMed Web of Science ®Google Scholar
• Da W, Zhang J, Zhang R, Zhu J. Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling. Int J Immunopathol Pharmacol. 2019;33:2058738419861600. doi:10.1177/2058738419861600
   Web of Science ®Google Scholar
• Binabaj MM, Soleimani A, Rahmani F, Avan A, Khazaei M, Fiuji H, Soleimanpour S, Ryzhikov M, Ferns GA, Bahrami A, et al. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression. Gene. 2019;706:131–9.: doi:10.1016/j.gene.2019.04.088
   PubMed Web of Science ®Google Scholar
• Abdeahad H, Avan A, Pashirzad M, Khazaei M, Soleimanpour S, Ferns GA, Fiuji H, Ryzhikov M, Bahrami A, Hassanian SM. The prognostic potential of long noncoding RNA HOTAIR expression in human digestive system carcinomas: A meta‐analysis. J Cell Physiol. 2019;234(7):10926–33. doi:10.1002/jcp.27918
   PubMed Web of Science ®Google Scholar
• Ding X-Q, Gu T-T, Wang W, Song L, Chen T-Y, Xue Q-C, Zhou F, Li J-M, Kong L-D. Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206 . Mol Nutr Food Res. 2015;59(12):2355–70. doi:10.1002/mnfr.201500370
   PubMed Web of Science ®Google Scholar
• Guo H, Xu Y, Fu Q. Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation. Tumour Biol. 2015;36(11):8511–7. doi:10.1007/s13277-015-3592-y
   PubMedGoogle Scholar
• Qiang Z, Meng L, Yi C, Yu L, Chen W, Sha W. Curcumin regulates the miR-21/PTEN/Akt pathway and acts in synergy with PD98059 to induce apoptosis of human gastric cancer MGC-803 cells. J Int Med Res. 2019;47(3):1288–97. doi:10.1177/0300060518822213
   PubMed Web of Science ®Google Scholar
• Chen J, Xu T, Chen C. The critical roles of miR-21 in anti-cancer effects of curcumin. Ann Transl Med. 2015;3
   Web of Science ®Google Scholar
• Wong MY, Yu Y, Walsh WR, Yang J-L. microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review). Int J Oncol. 2011;38(5):1189–95. doi:10.3892/ijo.2011.970
   PubMed Web of Science ®Google Scholar
• Cha YH, Kim NH, Park C, Lee I, Kim HS, Yook JI. MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling. Cell Cycle. 2012;11(7):1273–81. doi:10.4161/cc.19618
   PubMed Web of Science ®Google Scholar
• Sun C, Zhang S, Liu C, Liu X. Curcumin promoted miR-34a expression and suppressed proliferation of gastric cancer cells. Cancer Biother Radiopharmaceut. 2019;34(10):634–41. doi:10.1089/cbr.2019.2874
   PubMed Web of Science ®Google Scholar
• Hashemi M, Karami‐Tehrani F, Ghavami S, Maddika S, Los M. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway. Cell Prolif. 2005;38(5):269–85. doi:10.1111/j.1365-2184.2005.00349.x
   PubMed Web of Science ®Google Scholar
• Sun Q, Zhang W, Guo Y, Li Z, Chen X, Wang Y, Du Y, Zang W, Zhao G. Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer. Tumour Biol. 2016;37(10):13177–84. doi:10.1007/s13277-016-5221-9
   PubMedGoogle Scholar
• Lin Y, Liu AY, Fan C, Zheng H, Li Y, Zhang C, Wu S, Yu D, Huang Z, Liu F, et al. MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci Rep. 2015;5:9995: doi:10.1038/srep09995
   PubMed Web of Science ®Google Scholar
• Qu J, Li M, An J, Zhao B, Zhong W, Gu Q, Cao L, Yang H, Hu C. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling. Int J Oncol. 2015;47(6):2141–52. doi:10.3892/ijo.2015.3187
   PubMed Web of Science ®Google Scholar
• Xu N, Li Z, Yu Z, Yan F, Liu Y, Lu X, Yang W. MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells. PLoS One. 2014;9(12):e115300. doi:10.1371/journal.pone.0115300
   PubMed Web of Science ®Google Scholar
• Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013;333(2):213–21. doi:10.1016/j.canlet.2013.01.033
   PubMed Web of Science ®Google Scholar
• Lystad AH, Ichimura Y, Takagi K, Yang Y, Pankiv S, Kanegae Y, Kageyama S, Suzuki M, Saito I, Mizushima T, et al. Structural determinants in GABARAP required for the selective binding and recruitment of ALFY to LC3B-positive structures. EMBO Rep. 2014;15(5):557–65.: doi:10.1002/embr.201338003
   PubMed Web of Science ®Google Scholar
• Wang J, Song Y-X, Wang Z-N. Non-coding RNAs in gastric cancer. Gene. 2015;560(1):1–8. doi:10.1016/j.gene.2015.02.004
   PubMed Web of Science ®Google Scholar
• Li P-F, Chen S-C, Xia T, Jiang X-M, Shao Y-F, Xiao B-X, Guo J-M. Non-coding RNAs and gastric cancer. World J Gastroenterol. 2014;20(18):5411–9. doi:10.3748/wjg.v20.i18.5411
   PubMed Web of Science ®Google Scholar
• Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells . Febs J. 2012;279(17):3159–65. doi:10.1111/j.1742-4658.2012.08694.x
   PubMed Web of Science ®Google Scholar
• Liu G, Xiang T, Wu QF, Wang WX. Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19. Oncol Lett. 2016;12(6):5156–62. doi:10.3892/ol.2016.5354
   PubMed Web of Science ®Google Scholar
• Zhou S, Yao D, Guo L, Teng L. Curcumin suppresses gastric cancer by inhibiting gastrin-mediated acid secretion . FEBS Open Bio. 2017;7(8):1078–84. doi:10.1002/2211-5463.12237
   PubMed Web of Science ®Google Scholar
• Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013;73(5):1524–35. doi:10.1158/0008-5472.CAN-12-2796
   PubMed Web of Science ®Google Scholar
• Lu B, Yu L, Xu L, Chen H, Zhang L, Zeng Y. The effects of radix curcumae extract on expressions of VEGF, COX-2 and PCNA in gastric mucosa of rats fed with MNNG. CPB. 2010;11(3):313–7. doi:10.2174/138920110791111915
   Web of Science ®Google Scholar
• Cui S-X, Qu X-J, Xie Y-Y, Zhou L, Nakata M, et al. Curcumin inhibits telomerase activity in human cancer cell lines. Cancer Cells. 2006;8:9.
   Google Scholar
• Skyvalidas DΝ, Mavropoulos A, Tsiogkas S, Dardiotis E, Liaskos C, Mamuris Z, Roussaki-Schulze A, Sakkas LI, Zafiriou E, Bogdanos DP. Curcumin mediates attenuation of pro-inflammatory interferon γ and interleukin 17 cytokine responses in psoriatic disease, strengthening its role as a dietary immunosuppressant. Nutr Res. 2020;75:95–108. doi:10.1016/j.nutres.2020.01.005
   PubMed Web of Science ®Google Scholar
• Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr. 2019;59(1):89–101. doi:10.1080/10408398.2017.1358139
   PubMed Web of Science ®Google Scholar
• Ghandadi M, Sahebkar A. Curcumin: an effective inhibitor of interleukin-6. Curr Pharm Des. 2017;23(6):921–31. doi:10.2174/1381612822666161006151605
   PubMed Web of Science ®Google Scholar
• Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N. Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats. BioMed Res Int. 2012;2012.
   Google Scholar
• Gu X, Zhang Q, Zhang W, Zhu L. Curcumin inhibits liver metastasis of gastric cancer through reducing circulating tumor cells. Aging (Albany NY)). 2019;11(5):1501–9. doi:10.18632/aging.101848
   PubMedGoogle Scholar
• Da W, Zhu J, Wang L, Sun Q. Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model. Tumor Biol. 2015;36(7):5215–23. doi:10.1007/s13277-015-3178-8
   PubMedGoogle Scholar
• Liang Z, Wu R, Xie W, Geng H, Zhao L, Xie C, Wu J, Geng S, Li X, Zhu M, et al. Curcumin suppresses MAPK pathways to reverse tobacco Smoke-induced Gastric Epithelial-Mesenchymal Transition in Mice . Phytother Res. 2015;29(10):1665–71.: doi:10.1002/ptr.5398
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, Azuma T, Okazaki I-M, Honjo T, Chiba T. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007;13(4):470–6. doi:10.1038/nm1566
   PubMed Web of Science ®Google Scholar
• Zaidi SFH, Yamamoto T, Refaat A, Ahmed K, Sakurai H, Saiki I, Kondo T, Usmanghani K, Kadowaki M, Sugiyama T. Modulation of Activation‐Induced Cytidine Deaminase by Curcumin in Helicobacter pylori‐Infected Gastric Epithelial Cells. Helicobacter. 2009;14(6):588–95. doi:10.1111/j.1523-5378.2009.00724.x
   PubMed Web of Science ®Google Scholar
• Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr. 2006;30(1):45–51. doi:10.1177/014860710603000145
   PubMed Web of Science ®Google Scholar
• Foryst-Ludwig A, Neumann M, Schneider-Brachert W, Naumann M. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun. 2004;316(4):1065–72. doi:10.1016/j.bbrc.2004.02.158
   PubMed Web of Science ®Google Scholar
• De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadhyay AK. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother. 2009;53(4):1592–7. doi:10.1128/AAC.01242-08
   PubMed Web of Science ®Google Scholar
• Mahady GB, Pendland S, Yun G, Lu Z. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 2001;22:4179–81.
   Web of Science ®Google Scholar
• Werawatganon D, Somanawat K, Sintara K, Tumwasorn S, Klaikeaw N, Siriviriyakul P. Protective effect of curcumin decreases incidence of gastric cancer induced by Helicobacter pylori and N-methyl-N-nitrosourea in rats. Phcog Mag. 2019;15(63):402. doi:10.4103/pm.pm_621_18
   Web of Science ®Google Scholar
• Suganuma M, Yamaguchi K, Ono Y, Matsumoto H, Hayashi T, Ogawa T, Imai K, Kuzuhara T, Nishizono A, Fujiki H. TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells . Int J Cancer. 2008;123(1):117–22. doi:10.1002/ijc.23484
   PubMed Web of Science ®Google Scholar
• Wongsirisin P, Yodkeeree S, Limpakan S, Limtrakul P. Curcumin inhibition of the effects of Tip α induced cytokine expression in gastric cancer patients. PharmaNutrition. 2018;6(3):100–6. doi:10.1016/j.phanu.2018.05.003
   Web of Science ®Google Scholar
• Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res. 2005;11(18):6738–44. doi:10.1158/1078-0432.CCR-05-0171
   PubMed Web of Science ®Google Scholar
• Du B, Jiang L, Xia Q, Zhong L. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy. 2006;52(1):23–8. doi:10.1159/000090238
   PubMed Web of Science ®Google Scholar
• Lev-Ari S, Zinger H, Kazanov D, Yona D, Ben-Yosef R, Starr A, Figer A, Arber N. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Biomed Pharmacother. 2005;59:S276–S280. doi:10.1016/S0753-3322(05)80045-9
   PubMed Web of Science ®Google Scholar
• Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005;224(1):53–65. doi:10.1016/j.canlet.2004.10.051
   PubMed Web of Science ®Google Scholar
• Koo JY, Kim HJ, Jung K-O, Park K-Y. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J Med Food . 2004;7(2):117–21. doi:10.1089/1096620041224229
   PubMed Web of Science ®Google Scholar
• Chan MM, Fong D, Soprano KJ, Holmes WF, Heverling H. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents . J Cell Physiol. 2003;194(1):63–70. doi:10.1002/jcp.10186
   PubMed Web of Science ®Google Scholar
• Liu Y, Chang RL, Cui XX, Newmark HL, Conney AH. Synergistic effects of curcumin on all-trans retinoic acid-and 1 alpha, 25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells. Oncol Res. 1996;9:19–29.
   Web of Science ®Google Scholar
• Hour T-C, Chen J, Huang C-Y, Guan J-Y, Lu S-H, Pu Y-S. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation . Prostate. 2002;51(3):211–8. doi:10.1002/pros.10089
   PubMed Web of Science ®Google Scholar
• Shishodia S, Chaturvedi MM, Aggarwal BB. Role of curcumin in cancer therapy. Curr Probl Cancer. 2007;31(4):243–305. doi:10.1016/j.currproblcancer.2007.04.001
   PubMed Web of Science ®Google Scholar
• Yang H, Huang S, Wei Y, Cao S, Pi C, Feng T, Liang J, Zhao L, Ren G. Curcumin enhances the anticancer effect of 5-fluorouracil against gastric cancer through down-regulation of COX-2 and NF- κB Signaling Pathways . J Cancer. 2017;8(18):3697–706. doi:10.7150/jca.20196
   PubMed Web of Science ®Google Scholar
• He B, Wei W, Liu J, Xu Y, Zhao G. Synergistic anticancer effect of curcumin and chemotherapy regimen FP in human gastric cancer MGC-803 cells. Oncol Lett. 2017;14(3):3387–94. doi:10.3892/ol.2017.6627
   PubMed Web of Science ®Google Scholar
• Ebrahimifar M, Roudsari MH, Kazemi SM, Shahmabadi HE, Kanaani L, et al. Enhancing effects of curcumin on cytotoxicity of paclitaxel, methotrexate and vincristine in gastric cancer cells. Asian Pac J Cancer Prev: APJCP. 2017;18:65.:
   PubMedGoogle Scholar
• Tang X-q, Bi H, Feng J-q, Cao J-g. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol Sin. 2005;26(8):1009–16. doi:10.1111/j.1745-7254.2005.00149.x
   PubMed Web of Science ®Google Scholar
• Sen S, Sharma H, Singh N. Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun. 2005;331(4):1245–52. doi:10.1016/j.bbrc.2005.04.044
   PubMed Web of Science ®Google Scholar
• Yao J, Qian C, Shu T, Zhang X, Zhao Z, Liang Y. Combination treatment of PD98059 and DAPT in gastric cancer through induction of apoptosis and downregulation of WNT/β-catenin. Cancer Biol Ther. 2013;14(9):833–9. doi:10.4161/cbt.25332
   PubMed Web of Science ®Google Scholar
• Yang M, Huang C-Z. Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer. World J Gastroenterol. 2015;21(41):11673–9. doi:10.3748/wjg.v21.i41.11673
   PubMed Web of Science ®Google Scholar
• Bansal SS, Vadhanam MV, Gupta RC. Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin. Pharm Res. 2011;28(5):1121–30. doi:10.1007/s11095-011-0375-z
   PubMed Web of Science ®Google Scholar
• Loftsson T, Sigurđsson H, Másson M, Schipper N. Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs. Die Pharmazie. 2004;59:25–9.
   PubMed Web of Science ®Google Scholar
• Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm. 2002;244(1-2):127–35. doi:10.1016/s0378-5173(02)00323-x
   PubMed Web of Science ®Google Scholar
• Khafif A, Schantz SP, Chou T-C, Edelstein D, Sacks PG. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 1998;19(3):419–24. doi:10.1093/carcin/19.3.419
   PubMed Web of Science ®Google Scholar
• Cruz–Correa M, Shoskes DA, Sanchez P, Zhao R, Hylind LM, Wexner SD, Giardiello FM. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006;4(8):1035–8. doi:10.1016/j.cgh.2006.03.020
   PubMed Web of Science ®Google Scholar
• Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(04):353–6. doi:10.1055/s-2006-957450
   PubMed Web of Science ®Google Scholar
• Xu D-H, Wang S, Jin J, Mei X-T, Xu S-B. Dissolution and absorption researches of curcumin in solid dispersions with the polymers PVP. Asian J Pharmacodyn Pharmacokinet. 2006;6:343–9.
   Google Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm . 2007;330(1-2):155–63. doi:10.1016/j.ijpharm.2006.09.025
   PubMed Web of Science ®Google Scholar
• Peng L, Qiangsong T, Fengchao J, Liduan Z, Fangmin C, Fuqing Z, Jihua D, Yuefeng D. Preparation of curcumin prodrugs and theirin vitro anti-tumor activities. J Huazhong Univ Sci Technol [Med Sci]. 2005;25(6):668–70. doi:10.1007/BF02896166
   PubMedGoogle Scholar
• Shaikh J, Ankola D, Beniwal V, Singh D, Kumar MR. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009;37(3-4):223–30. doi:10.1016/j.ejps.2009.02.019
   PubMed Web of Science ®Google Scholar
• Kurzrock R, Li L. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. 2005.
   Google Scholar
• Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm. 2010;76(3):475–85. doi:10.1016/j.ejpb.2010.07.011
   PubMed Web of Science ®Google Scholar
• Gupta N, Aggarwal N. Bioavailability enhancement and targeting of stomach tumors using gastro-retentive floating drug delivery system of curcumin—“a technical note. Aaps Pharmscitech. 2008;9:810–3. doi:10.1208/s12249-008-9096-y
   PubMed Web of Science ®Google Scholar
• Zhang F, Koh GY, Jeansonne DP, Hollingsworth J, Russo PS, Vicente G, Stout RW, Liu Z. A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity. J Pharm Sci. 2011;100(7):2778–89. doi:10.1002/jps.22512
   PubMed Web of Science ®Google Scholar
• Dhivya R, Ranjani J, Rajendhran J, Mayandi J, Annaraj J. Enhancing the anti-gastric cancer activity of curcumin with biocompatible and pH sensitive PMMA-AA/ZnO nanoparticles. Mater Sci Eng C Mater Biol Appl. 2018;82:182–9. doi:10.1016/j.msec.2017.08.058
   PubMed Web of Science ®Google Scholar
• Jin R, Xia Y, Chen Q, Li W, Chen D, Ye H, Zhao C, Du X, Shi D, Wu J, et al. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells. Drug Des Devel Ther. 2016;10:979–95.: doi:10.2147/DDDT.S90081
   PubMed Web of Science ®Google Scholar
• Weng Q, Fu L, Chen G, Hui J, Song J, Feng J, Shi D, Cai Y, Ji J, Liang G, et al. Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcumin. Eur J Med Chem. 2015;103:44–55.: doi:10.1016/j.ejmech.2015.08.036
   PubMed Web of Science ®Google Scholar
• Jiang H, Geng D, Liu H, Li Z, Cao J. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Drug Deliv. 2016;23(9):3665–73. doi:10.1080/10717544.2016.1217954
   PubMed Web of Science ®Google Scholar
• Li Y, Li S, Han Y, Liu J, Zhang J, Li F, Wang Y, Liu X, Yao L. Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells. Eur J Pharmacol. 2008;591(1-3):252–8. doi:10.1016/j.ejphar.2008.06.065
   PubMed Web of Science ®Google Scholar
• Mu J, Wang X, Dong L, Sun P. Curcumin derivative L6H4 inhibits proliferation and invasion of gastric cancer cell line BGC-823. J Cell Biochem. 2019;120(1):1011–7. doi:10.1002/jcb.27542
   PubMed Web of Science ®Google Scholar
• Chen M, Zhou B, Zhong P, Rajamanickam V, Dai X, Karvannan K, Zhou H, Zhang X, Liang G. Increased intracellular reactive oxygen species mediates the anti-cancer effects of WZ35 via activating mitochondrial apoptosis pathway in prostate cancer cells. Prostate. 2017;77(5):489–504. doi:10.1002/pros.23287
   PubMed Web of Science ®Google Scholar
• Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307(2):G196–G204. doi:10.1152/ajpgi.00077.2014
   PubMed Web of Science ®Google Scholar
• Zou P, Xia Y, Chen W, Chen X, Ying S, Feng Z, Chen T, Ye Q, Wang Z, Qiu C, et al. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells. Oncotarget. 2016;7(14):18050–64.: doi:10.18632/oncotarget.7633
   PubMedGoogle Scholar
• Yoo M-H, Xu X-M, Carlson BA, Gladyshev VN, Hatfield DL. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem. 2006;281(19):13005–8. doi:10.1074/jbc.C600012200
   PubMed Web of Science ®Google Scholar
• Fan C, Chen J, Wang Y, Wong Y-S, Zhang Y, Zheng W, Cao W, Chen T. Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway. Free Radic Biol Med. 2013;65:305–16. doi:10.1016/j.freeradbiomed.2013.07.002
   PubMed Web of Science ®Google Scholar
• Ye C, Wang W, Xia G, Yu C, Yi Y, Hua C, Tu F, Shen L, Chen C, Sun W, et al. a novel curcumin derivative cl-6 exerts antitumor effect in human gastric cancer cells by inducing apoptosis through Hippo-YAP signaling pathway. Onco Targets Ther. 2019;12:2259–69. doi:10.2147/OTT.S196914
   PubMed Web of Science ®Google Scholar
• Jakubek M, Kejík Z, Kaplánek R, Hromádka R, Šandriková V, Sýkora D, Antonyová V, Urban M, Dytrych P, Mikula I, et al. Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer. Biomed Pharmacother. 2019;118:109278. doi:10.1016/j.biopha.2019.109278
   PubMed Web of Science ®Google Scholar
• Yoshida T, Maruyama T, Miura M, Inoue M, Fukuda K, Shimazu K, Taguchi D, Kanda H, Oshima M, Iwabuchi Y, et al. Dietary intake of pyrolyzed deketene curcumin inhibits gastric carcinogenesis. J Funct Foods. 2018;50:192–200. doi:10.1016/j.jff.2018.09.033
   Web of Science ®Google Scholar
• Alibeiki F, Jafari N, Karimi M, Dogaheh HP. Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells. Sci Rep. 2017;7(1):1–9. doi:10.1038/s41598-017-02666-4
   PubMed Web of Science ®Google Scholar
• Baell JB. Feeling nature's PAINS: Natural Products, natural product drugs, and pan assay interference compounds (PAINS)). J Nat Prod. 2016;79(3):616–28. doi:10.1021/acs.jnatprod.5b00947
   PubMed Web of Science ®Google Scholar
• Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin: miniperspective. J Med Chem. 2017;60(5):1620–37. doi:10.1021/acs.jmedchem.6b00975
   PubMed Web of Science ®Google Scholar
• Dahlin JL, Walters MA. The essential roles of chemistry in high-throughput screening triage. Future Med Chem. 2014;6(11):1265–90. doi:10.4155/fmc.14.60
   PubMed Web of Science ®Google Scholar
• Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 2001;7(7):1894–900.:
   PubMed Web of Science ®Google Scholar
• Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiology Biomarkers & Prevention. 2005;14:120–5.
   PubMed Web of Science ®Google Scholar
• Irving GR, Iwuji COO, Morgan B, Berry DP, Steward WP, Thomas A, Brown K, Howells LM. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial. Trials. 2015;16(1) doi:10.1186/s13063-015-0641-1
   PubMed Web of Science ®Google Scholar
• James MI, Iwuji C, Irving G, Karmokar A, Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR, et al. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Lett. 2015;364(2):135–41.: doi:10.1016/j.canlet.2015.05.005
   PubMed Web of Science ®Google Scholar
• Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14(14):4491–9. doi:10.1158/1078-0432.CCR-08-0024
   PubMed Web of Science ®Google Scholar
• Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res. 2011;4(3):354–64.: doi:10.1158/1940-6207.CAPR-10-0098
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847–54.: doi:10.1158/1078-0432.CCR-04-0744
   PubMed Web of Science ®Google Scholar
• NCT02782949: Curcumin in preventing gastric cancer in patients with chronic atrophic gastritis or gastric intestinal metaplasia. http://clinicaltrialsgov/ct2/show/NCT02782949., 2016.
   Google Scholar
• Di Mario F, Cavallaro LG, Nouvenne A, Stefani N, Cavestro GM, Iori V, Maino M, Comparato G, Fanigliulo L, Morana E, et al. A Curcumin‐Based 1‐Week Triple Therapy for Eradication of Helicobacter pylori Infection: Something to Learn From Failure?. Helicobacter. 2007;12(3):238–43.: doi:10.1111/j.1523-5378.2007.00497.x
   PubMed Web of Science ®Google Scholar
• Nci D. Clinical development plan: curcumin. J Cell Biochem S. 1996;26:72–85.
   Google Scholar
• Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002;11:535–40.:
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee Y. Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review. Drugs Fut. 2010;35(2):113. doi:10.1358/dof.2010.035.02.1426640
   Web of Science ®Google Scholar
• Dcodhar S, Sethi R, Srimal R. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 2013;138
   Google Scholar
• Berretta S, Berretta M, Fiorica F, Di Francia R, Magistri P, Bertola G, Fisichella R, Canzonieri V, Tarantino G, Di Benedetto F, et al. Multimodal approach of advanced gastric cancer: based therapeutic algorithm. Eur Rev Med Pharmacol Sci. 2016;20(19):4018–31.:
   PubMed Web of Science ®Google Scholar